Anteris Technologies Global (ASX:AVR) 6-Month Price Index: 1.62 (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:AVR Anteris Technologies Global Corp ASX:AVR
46 GF Score
Price A$13.00
! 7 Warning Signs
View Full Analysis

What is Anteris Technologies Global 6-Month Price Index?

Anteris Technologies Global ASX:AVR +7.44% 46 6-Month Price Index is 1.62 as of Aug. 17, 2026. GuruFocus rates ASX:AVR with a GF Score™ of 46/100. The stock has 7 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-08-17), Anteris Technologies Global's 6-Month Price Index is 1.62.

Anteris Technologies Global  (ASX:AVR) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Anteris Technologies Global 6-Month Price Index Related Terms

ASX:AVR vs BVS, SIBN, INMD: 6-Month Price Index Comparison

For the Medical Devices subindustry, Anteris Technologies Global's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ASX:AVR
46GF Score
Anteris Technologies Global Corp ASX:AVR
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anteris Technologies Global  (ASX:AVR) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 1.62 mean?
Anteris Technologies Global (ASX:AVR) has a 6-Month Price Index of 1.62 as of Aug. 17, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Anteris Technologies Global and its competitors.
Is Anteris Technologies Global's 6-Month Price Index too high?
Anteris Technologies Global's current 6-Month Price Index is 1.62. Overall, Anteris Technologies Global has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Anteris Technologies Global's 6-Month Price Index compare to BVS and SIBN?
Anteris Technologies Global's 6-Month Price Index of 1.62 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Medical Devices & Instruments company?
A good 6-Month Price Index depends on the Medical Devices & Instruments industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Anteris Technologies Global and its competitors. Anteris Technologies Global's current 6-Month Price Index is 1.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anteris Technologies Global stock overvalued right now?
Anteris Technologies Global (ASX:AVR) has a current 6-Month Price Index of 1.62. The current 6-Month Price Index is 1.62. Anteris Technologies Global's overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Anteris Technologies Global (ASX:AVR), the current 6-Month Price Index is 1.62 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anteris Technologies Global Business Description

Other Exchanges AVR:USA
Address 9 Sherwood Road, Level 3, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
46GF Score

Get the complete analysis for ASX:AVR

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$13.00
Price